InvestorsHub Logo
Followers 0
Posts 583
Boards Moderated 0
Alias Born 07/18/2006

Re: Krombacher post# 8499

Friday, 05/07/2010 3:45:30 PM

Friday, May 07, 2010 3:45:30 PM

Post# of 14825
The Urine test was a lab test, not a rapid test I believe. The market for such a test has extremely diminished.

Their main push is for the Aware HIV OMT(oral) rapid test. They do have approval for the test in quite a few countries and is also on the USAID waiver list. The only "main" competitor is Orasure and Calypte does have some advantages over it (longer shelf life, possibly a bit less expensive, etc.). They appear to be working on a new AWARE 2 test that could be used in the U.S. Of course they will have to go through clinical trials and submission. This could be huge if the U.S. ever approves an OTC version of HIV tests, but that seems to have been on-going now for many, many years.

The current obstacle remains cost in relation to rapid blood tests, even though some reports have showed the OMT test to be cheaper in the long run.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.